The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
Authors:
Open Access
- 30 January 2015
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (9) , 6472-6498
Abstract
The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapyKeywords
This publication has 147 references indexed in Scilit:
- miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1The American Journal of Pathology, 2012
- Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressorsBritish Journal of Cancer, 2012
- The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cellsThe EMBO Journal, 2011
- Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem CellsMolecular Cell, 2010
- Diverse Endonucleolytic Cleavage Sites in the Mammalian Transcriptome Depend upon MicroRNAs, Drosha, and Additional NucleasesMolecular Cell, 2010
- mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1Molecular Cell, 2010
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem CellsCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008